Literature DB >> 17729414

Prevalence of overweightedness in patients with gastro-esophageal reflux.

Luca Piretta1, Federico Alghisi, Fiorella Anzini, Enrico Corazziari.   

Abstract

AIM: To evaluate whether the prevalence of overweight and obese conditions is increased in gastro-esophageal reflux disease (GERD) patients (with 24-h pathological pH recordings) in comparison to general population.
METHODS: A total of 196 consecutive patients (103 females, age range 18-83 years) with symptoms of gastro-esophageal reflux (GER) and 24-h pathological esophageal pH-metry. Body mass index (BMI) of the patients was calculated and its distribution (%) was compared with that of the Italian general population as assessed by National Bureau of Census (ISTAT). To evaluate the association of GERD with weight categories, the binomial test was employed. P < 0.05 was considered statistically significant.
RESULTS: In males, overweightedness (BMI 25-25.9) was present in 43% of GERD patients vs 41.8% of Italian population (IP) (ns), obesity (BMI > or = 30) in 10.9% vs 9.1% (ns). In females overweight was present in 34.9% of GERD patients vs 25.7% of IP (P < 0.01), obesity in 13.6% of GERD patients vs 9.1% of IP (P < 0.01). No statistically significant differences were noted in different age classes.
CONCLUSION: In comparison to the Italian general population, the prevalence of overweightedness and obesity is increased in female but not in male patients with ascertained gastro-esophageal reflux disease.

Entities:  

Mesh:

Year:  2007        PMID: 17729414      PMCID: PMC4611835          DOI: 10.3748/wjg.v13.i34.4602

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Effect of intraduodenal fat on lower oesophageal sphincter function and gastro-oesophageal reflux.

Authors:  R H Holloway; E Lyrenas; A Ireland; J Dent
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

2.  Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey.

Authors:  C E Ruhl; J E Everhart
Journal:  Ann Epidemiol       Date:  1999-10       Impact factor: 3.797

3.  Obesity correlates with gastroesophageal reflux.

Authors:  B L Fisher; A Pennathur; J L Mutnick; A G Little
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

4.  Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.

Authors:  M Voutilainen; P Sipponen; J P Mecklin; M Juhola; M Färkkilä
Journal:  Digestion       Date:  2000       Impact factor: 3.216

Review 5.  Functional esophageal disorders.

Authors:  Jean Paul Galmiche; Ray E Clouse; András Bálint; Ian J Cook; Peter J Kahrilas; William G Paterson; Andre J P M Smout
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Risk factors associated with symptoms of gastroesophageal reflux.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

7.  Does massive obesity promote abnormal gastroesophageal reflux?

Authors:  L Lundell; M Ruth; N Sandberg; M Bove-Nielsen
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Gastroesophageal reflux in obese patients is not reduced by weight reduction.

Authors:  A Kjellin; S Ramel; S Rössner; K Thor
Journal:  Scand J Gastroenterol       Date:  1996-11       Impact factor: 2.423

9.  Three year follow up of patients with gastrooesophageal reflux disease.

Authors:  N E Schindlbeck; A G Klauser; G Berghammer; W Londong; S A Müller-Lissner
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

10.  Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension.

Authors:  L M Mathus-Vliegen; G N Tytgat
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 2.566

View more
  7 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Quantitative assessment of visceral fat in morbidly obese patients by means of wide-bore MRI and its relation to lower esophageal sphincter pressure and signs of gastroesophageal reflux.

Authors:  Fabian Springer; Manuel Schwarz; Jürgen Machann; Andreas Fritsche; Claus D Claussen; Fritz Schick; Joachim H Schneider
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

3.  Clinical and endoscopic features of Chinese reflux esophagitis patients.

Authors:  Wei Li; Shu-Tian Zhang; Zhong-Lin Yu
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

4.  Multichannel intraluminal impedance measurement of gastroesophageal reflux in patients with different stages of morbid obesity.

Authors:  Juliane M E Schneider; Björn L D M Brücher; Markus Küper; Kathrin Saemann; Alfred Königsrainer; Joachim H Schneider
Journal:  Obes Surg       Date:  2008-07-22       Impact factor: 4.129

Review 5.  The association between metabolic syndrome and erosive esophagitis: A systematic review and meta-analysis.

Authors:  Milad Azami; Majid Salamati; Reza Ranjbar; Amirhossein Sahebkar
Journal:  EXCLI J       Date:  2021-11-08       Impact factor: 4.068

6.  Dietary intake and risk for reflux esophagitis: a case-control study.

Authors:  Ping Wu; Xiao-Hu Zhao; Zi-Sheng Ai; Hui-Hui Sun; Ying Chen; Yuan-Xi Jiang; Yi-Li Tong; Shu-Chang Xu
Journal:  Gastroenterol Res Pract       Date:  2013-04-16       Impact factor: 2.260

Review 7.  Is Metabolic Syndrome Considered to Be a Risk Factor for Gastroesophageal Reflux Disease (Non-Erosive or Erosive Esophagitis)?: A Systematic Review of the Evidence.

Authors:  Mohammad Mohammadi; Nahid Ramezani Jolfaie; Rooya Alipour; Mitra Zarrati
Journal:  Iran Red Crescent Med J       Date:  2016-08-08       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.